Freenome, Inc. (FRNM)
NASDAQ: FRNM · Real-Time Price · USD
13.63
+0.18 (1.34%)
At close: Aug 19, 2026, 4:00 PM EDT
13.67
+0.04 (0.29%)
After-hours: Aug 19, 2026, 7:34 PM EDT
Freenome Revenue
Freenome had revenue of $4.22M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $34.24M. In the year 2025, Freenome had annual revenue of $30.41M with 955.14% growth.
Revenue (ttm)
$34.24M
Revenue Growth
+955.14%
P/S Ratio
44.93
Revenue / Employee
$94,317
Employees
363
Market Cap
1.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.41M | 27.53M | 955.14% |
| Dec 31, 2024 | 2.88M | 780.00K | 37.11% |
| Dec 31, 2023 | 2.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
FRNM News
- 1 day ago - Freenome files to sell 75.19M shares of common stock for holders - TheFly
- 1 day ago - Freenome initiated with a Buy at TD Cowen - TheFly
- 2 days ago - Freenome initiated with a Buy at BTIG - TheFly
- 2 days ago - Freenome granted Breakthrough Device Designation for SimpleScreen Lung - TheFly
- 2 days ago - Freenome initiated with a Buy at Jefferies - TheFly
- 3 days ago - Freenome initiated with an Outperform at Leerink - TheFly
- 7 days ago - FDA Grants Breakthrough Device Designation to Freenome's Blood-Based SimpleScreen™ Lung Cancer Screening Test - GlobeNewsWire
- 23 days ago - FDA approves Freenome's blood test for colorectal cancer screening - Reuters